Recursion Pharmaceuticals, Inc.
做多

RXRX

164
just perspective company, they have several interesting projects in different spheres(genetic, neuro, cancer) + good indicator dynamic (still w8 for ichi confirmation, but rsi and F&G are looking good), anyway hard to talk about goals for now

免责声明

这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。